ArticleJournal for immunotherapy of cancer2025

PROTAC-based nanoantigens promote cross-presentation and trafficking of dendritic cell vaccine for enhanced antitumor efficacy.

Peng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.